To further verify that macrophage C5aR controls CXCL9 expression and tumor progression, we treated WT and C5aR−/− tumor-bearing mice with clodronate liposomes, which have been widely used to deplete macrophages in vivo.38 The gene discussed is CXCL9; the disease is neoplasm.